Rx (Prescription Medicine)
USD $ 80.00
Dash 70mg Tablet 是一种含有活性成分 Tofacitinib 的药物，它是一种 Janus kinase (JAK) 抑制剂。它通过阻断体内参与炎症和免疫反应的某些酶的作用来发挥作用。通过减少这种炎症活性，Dash 70mg Tablet 可帮助缓解多种自身免疫性疾病相关的症状。
该药主要用于治疗对甲氨蝶呤反应不足或不能耐受的成人中度至重度类风湿性关节炎。它也用于成人的活性银屑病关节炎和溃疡性结肠炎。典型剂量为每日一次 70mg 片，但应始终按医疗专业人员的处方服用。根据个体的反应和耐受性，可能需要调整剂量。
常见不良反应可能包括上呼吸道感染、头痛、腹泻以及血液胆固醇水平升高。虽然不常见但可能出现的严重不良反应包括严重感染、血栓以及某些类型的癌症。患者在开始使用 Dash 70mg Tablet 前，应向医生报告任何既往病史，尤其是感染、肝肾功能问题或癌症史。正确保存药物至关重要，需置于室温、远离潮湿和热源，并确保儿童接触不到。
| Brand Name | |
|---|---|
| Molecule | |
| Strength | |
| Pack Quantity | |
| Medicine Form | |
| Medicine Type | |
| Rx Status | |
| Country Of Origin | |
| Packaging Type |
其他品牌的 Dasatinib 70 mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
